Prosecution Insights
Last updated: April 19, 2026

Examiner: KIM, YOUNG J

Tech Center 1600 • Art Units: 1637 1681

This examiner grants 65% of resolved cases

Performance Statistics

64.8%
Allow Rate
+4.8% vs TC avg
1159
Total Applications
+17.7%
Interview Lift
1217
Avg Prosecution Days
Based on 1098 resolved cases, 2023–2026

Rejection Statute Breakdown

5.0%
§101 Eligibility
16.6%
§102 Novelty
32.5%
§103 Obviousness
33.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18565027 POLYNUCLEOTIDE SEQUENCING USING IONOPHORES Non-Final OA Illumina, Inc.
19336117 Single Cell Nucleic Acid Detection and Analysis Final Rejection President and Fellows of Harvard College
18537266 CONTROLLED ROLLING CIRCLE AMPLIFICATION Non-Final OA Singular Genomics Systems, Inc.
17924639 QUADRUPLEX-BASED DETECTION OF A TARGET NUCLEIC ACID Non-Final OA Ohio State Innovation Foundation
18399109 METHODS, COMPOSITIONS, AND SYSTEMS FOR ENHANCING SPATIAL ANALYSIS OF ANALYTES IN A BIOLOGICAL SAMPLE Non-Final OA 10x Genomics, Inc.
17956596 METHODS AND KITS FOR IDENTIFYING, DIAGNOSING AND TREATING PROSTATE CARCINOMAS Final Rejection 10x Genomics, Inc.
17879871 Ultraspecific Nucleic Acid Sensors for Low-Cost Liquid Biopsies Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
17557010 METHOD FOR PROVIDING QUANTITATIVE INFORMATION OF TARGETS AND DEVICE USING THE SAME Non-Final OA KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
18279714 TUMOR CELL IDENTIFICATION BY MAPPING MUTATIONS IN BULK DNA SEQUENCES TO SINGLE CELL RNA SEQUENCES Non-Final OA AMAZON TECHNOLOGIES, INC.
15996236 MICROFLUIDIC DEVICES Final Rejection Bio-Rad Laboratories, Inc.
18173097 ALL-IN-ONE LUMINESCENCE-BASED POINT-OF-CARE TESTING DEVICE FOR VIRUS DIAGNOSIS Non-Final OA The Hong Kong Polytechnic University
17924018 COMPOSITION FOR NUCLEIC ACID ANALYSIS, NUCLEIC ACID ANALYZING METHOD, AND NUCLEIC ACID ANALYZER Non-Final OA HITACHI HIGH-TECH CORPORATION
18503936 Highly Sensitive EGFRvIII Detection Non-Final OA The General Hospital Corporation
18452628 MARKER AND METHOD FOR ANALYSING BIOLOGICAL SAMPLES Non-Final OA LEICA MICROSYSTEMS CMS GMBH
18042265 KIT AND METHOD FOR ISOTHERMAL RAPID DETECTION OF SARS-COV-2 VIRUS NUCLEIC ACID Non-Final OA SHANGHAI JIAO TONG UNIVERSITY
18547904 MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY Non-Final OA INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS
17677713 ON-CHIP OPTICAL REAL-TIME DNA SEQUENCING Final Rejection Seagate Technology LLC
18631561 MICROFLUIDIC SYSTEM FOR AMPLIFYING AND DETECTING POLYNUCLEOTIDES IN PARALLEL Final Rejection Handylab, Inc.
17754018 Colour Tunable Luminescent Bidentate Platinum (II) Complexes for Probing Mismatch DNA Final Rejection THE UNIVERSITY OF HONG KONG
17015829 Smartphone PCR Device Final Rejection Roche Molecular Systems, Inc.
18303700 MICROFLUIDIC DEVICES AND OBSERVATION METHODS Non-Final OA TOPPAN Inc.
18568145 A Molecular Tool And Use Thereof In A Label-Free Method For Detecting A Target Nucleic Acid In A Sample Non-Final OA ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
17912220 METHOD FOR DETECTING TARGET NUCLEIC ACID Final Rejection KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
18147647 COMPOSITIONS AND METHODS FOR IDENTIFYING CELL TYPES Non-Final OA GRAIL, LLC
17985485 SYSTEMS AND METHODS FOR GENERATION OF EMULSIONS WITH SUITABLE CLARITY WITH APPLICATIONS OF USE Final Rejection Enumerix, Inc.
18580232 USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE RISK OF COMPLICATIONS IN A PATIENT ADMITTED TO A HEALTHCARE FACILITY Non-Final OA BIOASTER
18014878 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT Non-Final OA BIOASTER
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES Non-Final OA NUCLEIX LTD.
18564908 METHODS FOR MEASURING PROTEIN-DNA INTERACTIONS WITH LONG-READ DNA SEQUENCING Non-Final OA CHAN ZUCKERBERG BIOHUB, INC.
18563307 METHODS FOR FRAGMENTING COMPLEMENTARY DNA Non-Final OA CZ Biohub SF, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month